We are live on ! Find out more
PTCT icon

PTC Therapeutics

118 hedge funds and large institutions have $202M invested in PTC Therapeutics in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more call options, than puts

Call options by funds: $4.23M | Put options by funds: $1.99M

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

7% more capital invested

Capital invested by funds: $189M → $202M (+$13M)

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

1% less funds holding

Funds holding: 119118 (-1)

Holders
118
Holders Change
-1
Holders Change %
-0.84%
% of All Funds
3.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
44
Reduced
33
Closed
22
Calls
$4.23M
Puts
$1.99M
Net Calls
+$2.24M
Net Calls Change
+$739K
Name Holding Trade Value Shares
Change
Change in
Stake
MLICM
76
Metropolitan Life Insurance Company (MetLife)
New York
$166K
CCMH
77
Cornerstone Capital Management Holdings
New York
$159K +$166K +22,600 New
CG
78
Cutler Group
California
$158K +$46.8K +6,380 +39%
California Public Employees Retirement System
79
California Public Employees Retirement System
California
$154K -$5.13K -700 -3%
Morgan Stanley
80
Morgan Stanley
New York
$151K +$76.4K +10,419 +94%
SCM
81
Stonebridge Capital Management
California
$150K -$391K -53,325 -71%
State Board of Administration of Florida Retirement System
82
State Board of Administration of Florida Retirement System
Florida
$147K +$3.2K +436 +2%
AIG
83
American International Group
New York
$134K -$4.97K -678 -3%
TRSOTSOK
84
Teachers Retirement System of the State of Kentucky
Kentucky
$121K
Federated Hermes
85
Federated Hermes
Pennsylvania
$118K +$124K +16,868 New
Citigroup
86
Citigroup
New York
$109K -$159K -21,687 -58%
1CM
87
1492 Capital Management
Wisconsin
$109K -$10.1K -1,372 -8%
Barclays
88
Barclays
United Kingdom
$103K +$1.75K +238 +2%
VOYA Investment Management
89
VOYA Investment Management
Georgia
$102K
Jane Street
90
Jane Street
New York
$96K -$304K -41,446 -75%
JMPWA
91
JP Morgan Private Wealth Advisors
California
$90K +$94.2K +12,840 New
MAM
92
Meeder Asset Management
Ohio
$86K +$89.4K +12,183 New
HCM
93
Highbridge Capital Management
New York
$86K +$89.8K +12,239 New
Tudor Investment Corp
94
Tudor Investment Corp
Connecticut
$74K -$535K -72,927 -87%
PCM
95
Prelude Capital Management
New York
$62K +$64.5K +8,800 New
UBS Group
96
UBS Group
Switzerland
$60K -$275K -37,487 -81%
Legal & General Group
97
Legal & General Group
United Kingdom
$58K
Public Employees Retirement Association of Colorado
98
Public Employees Retirement Association of Colorado
Colorado
$56K
Canada Life
99
Canada Life
Manitoba, Canada
$32K
Royal Bank of Canada
100
Royal Bank of Canada
Ontario, Canada
$30K -$35.7K -4,866 -53%

PTCT Hedge Fund Activity: Q2 2016 in Review

118 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q2 2016, worth a combined $202M — up 6.9% from $189M a quarter earlier.

Fund positioning in PTCT was balanced in Q2 2016: 22 funds opened new positions, 22 closed out, 44 added to existing stakes and 33 trimmed.

The largest buyer was Pictet Asset Management (UK), adding an estimated $7.5M. The largest seller was Sectoral Asset Management, cutting an estimated $14.4M.

  • 118 institutional investors held PTC Therapeutics (PTCT) as of Q2 2016, down from 119 in Q1 2016.
  • Funds reported $202M of PTC Therapeutics stock for Q2 2016, up 6.9% quarter-over-quarter.
  • 22 funds opened new PTC Therapeutics positions in Q2 2016 and 22 closed out, a net change of 0 holders.
  • The largest PTC Therapeutics buyer in Q2 2016 was Pictet Asset Management (UK), an estimated $7.5M added.
  • The largest PTC Therapeutics seller in Q2 2016 was Sectoral Asset Management, an estimated $14.4M sold.

Based on aggregated 13F filings for Q2 2016.